G-Rex Grant Program

About ScaleReady

ScaleReady, founded in 2018, commercializes the G-Rex (gas permeable rapid expansion) platform, a novel bioreactor technology for cell therapy manufacturing. Its core innovation is a gas-permeable membrane that allows for simplified, scalable cell culture without the need for frequent media exchanges or complex perfusion systems. The platform is reportedly used in the production of five commercially approved drug products and by a significant portion of US clinical trial sponsors, positioning it as a key enabling technology in the CGT space. The company operates a substantial grant program to foster adoption and advance next-generation therapies.

Therapeutic Areas